Dr Charles Naltet
- Specialty
- Medical oncologist, lung expert
- Title
- Head of thoracic oncology unit
- Hospital
- Hôpital Saint-Joseph (Paris)
- Latest articles
-
- Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE. (Aug 26, 2026)
- Safety and efficacy of concurrent radiation therapy with amivantamab in patients with advanced EGFR- or MET-altered non-small cell lung cancer. (Jul 26, 2026)
- The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinib. (May 13, 2026)
- The Impact of Dual Cannabis and Tobacco Smoking in Young Patients With Lung Cancer: Results From the Prospective "Environment and Lung Cancer" Study. (Mar 1, 2026)
- Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial. (Sep 18, 2025)